UCL 2077
CAS No. 918311-87-2
UCL 2077( —— )
Catalog No. M26857 CAS No. 918311-87-2
UCL 2077 is a subtype-selective blocker of the epilepsy-associated KCNQ channels and it also is a selective slow-afterhyperpolarization channel blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 105 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 136 | In Stock |
|
| 25MG | 246 | In Stock |
|
| 50MG | 356 | In Stock |
|
| 100MG | 496 | In Stock |
|
| 200MG | 685 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUCL 2077
-
NoteResearch use only, not for human use.
-
Brief DescriptionUCL 2077 is a subtype-selective blocker of the epilepsy-associated KCNQ channels and it also is a selective slow-afterhyperpolarization channel blocker.
-
DescriptionUCL 2077 is a subtype-selective blocker of the epilepsy-associated KCNQ channels and it also is a selective slow-afterhyperpolarization channel blocker,with IC50 of 500 nM in hippocampal neurons in culture, having minimal effects on Ca2+ channels, action potentials, input resistance, and the medium afterhyperpolarization.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number918311-87-2
-
Formula Weight350.465
-
Molecular FormulaC25H22N2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (356.67 mM)
-
SMILESC(NC(c1ccccc1)(c1ccccc1)c1ccccc1)c1cccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yi-Ping Chin, et al. Synthesis and evaluation of antibacterial activities of 5,7-dihydroxycoumarin derivatives. Arch Pharm (Weinheim). 2011 Jun;344(6):386-93.
molnova catalog
related products
-
(E)-3-(Naphth-1-yl)a...
(E)-3-(Naphth-1-yl)acrylic acid (3-(1-Naphthyl)acrylic acid) is a biochemical reagent that can be used to synthesize a variety of compounds and participate in many reactions in the body.
-
Diroximel Fumarete
Diroximel fumarate, a prodrug of monomethyl fumarate in a controlled-release formulation, rapidly and potently converts to MMF in the body.
-
L-693,403 maleate
L-693,403 maleate has analgesic activity.
Cart
sales@molnova.com